First, the hype of this concept plate has come to an end, and this stock has been adjusted with the plate;

2. On August 4th, Neptune Bio had a large transaction of 65.438+0.37 billion yuan, which may be that the fixed-income institutions made profits and fled, thus suppressing the stock price.

Shenzhen Wanghai Bioengineering Co., Ltd. is a large-scale comprehensive enterprise group focusing on biopharmaceutical industry, which was established in 1989 and headquartered in Shenzhen.

Shenzhen Wanghai Bioengineering Co., Ltd. includes pharmaceutical product research and development, pharmaceutical industrial manufacturing and pharmaceutical commercial circulation. 1998 12 18, Neptune Bio was listed and traded in Shenzhen Stock Exchange.

On July 20th, 20021year, the Fortune China 500 list was released, and Shenzhen Wanghai Bioengineering Co., Ltd. ranked 272nd.

Shenzhen Wanghai Bioengineering Co., Ltd. is a large-scale comprehensive enterprise group focusing on biopharmaceutical industry, which was established in 1989 and headquartered in Shenzhen.

The company, formerly known as Shenzhen Shekou Wanghai Bioengineering Co., Ltd., was established on February 3, 20 14 with the approval of Shenzhen Nanshan District People's Government in the document of Shennanfu (1992) 1 18. 1On July 25th, 1996, Shenzhen Securities Regulatory Bureau approved the reorganization of public joint-stock companies with Shenzhen Securities Office Reply (1996) No.68. On April 6th, 1997, the name of the joint-stock company to be established was Shenzhen Wanghai Bioengineering Co., Ltd. with the approval of Shenzhen Administration for Industry and Commerce, with a share capital of 57.3 million yuan/kloc-0. China Securities Regulatory Commission approved the company to issue RMB ordinary shares 1 965438+ 10,000 shares to the public by Jian Zheng Fa Zi [1998]2 14, and issued them on June 5438+0998 12.

Scope: scope:

1. Production and operation of biochemical raw materials, products, reagents and other related products (except franchised, specially controlled and monopolized commodities);

2. Develop biochemical products and other related products;

3. Self-operated import and export business (handled according to the provisions of Shenzhen Trade Management Certificate No.70);

4. Invest in industries (specific projects shall be declared separately);

5. prepackaged foods (excluding reheated prepackaged foods) and dairy products (including infant formula milk powder); Wholesale.